Roche announced on Thursday that its new Cobas 5800 molecular instrument has received CE marking.

On November 18, Chinese Academy of Sciences (CAS) announced the list of elected academicians of CAS in 2021. According to regulations, 65 academicians and 25 foreign academicians of CAS were elected in 2021.

Wall Street analysts contend that Johnson & Johnson's recent decision to split off the consumer health unit as its own company is likely to boost growth and increase operating margins for the remaining pharmaceutical and medical device segments.

The creation of nanoscale computers for use in precision health care has long been a dream of many scientists and health care providers. Now, the research paves the way for the construction of complex nanoscale computers for the prevention and treatment of cancer and other diseases.

Burning Rock Biotech reported on Tuesday morning that its third quarter revenues rose about 2 percent year over year.

Illumina and Genetic Alliance said on Tuesday that they are launching a new program to expand patient access to whole-genome sequencing around the world.

Roche has again been recognized as one of the most sustainable companies in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance.

On November 15, 2021, Vazyme Biotech Co., Ltd. (hereinafter referred to as "Vazyme") was listed on SSE STAR Market. Stock abbreviation: Vazyme, stock code: 688105. The issue price is 55 yuan/share, and the opening price is 74 yuan/share.

Siemens Healthineers (ETR:SHL) shares ticked up today on fourth-quarter results that topped the consensus sales forecast.

An artificial intelligence (AI)-based technology rapidly diagnoses rare disorders in critically ill children with high accuracy, according to a report by researchers from University of Utah (U Of U) Health, Fabric Genomics, and collaborators on a study led by Rady Children’s Hospital in San Diego.

DiaSorin said in Q3 it saw a strong recovery of non-COVID test sales including for latent tuberculosis and other infectious diseases as well as gastrointestinal infections.

On November 10, Wuhan Landing Med officially announced that it had completed the round-D financing of RMB 320 million, which was led by Ali Health and followed by Ether Capital.

The funding will be used to provide purchase commitments to manufacturers so they can scale up test production.

Meridian Bioscience announced on Wednesday that its Revogene SARS-CoV-2 test has received Emergency Use Authorization from the US Food and Drug Administration.

Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month.